Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Sustained virologic response"" wg kryterium: Temat


Tytuł :
Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response.
Autorzy :
Harimoto N; Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, Graduate School of Medicine, Gunma University, Maebashi, Japan .
Itoh S; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yamanaka T; Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, Graduate School of Medicine, Gunma University, Maebashi, Japan.
Hagiwara K; Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, Graduate School of Medicine, Gunma University, Maebashi, Japan.
Ishii N; Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, Graduate School of Medicine, Gunma University, Maebashi, Japan.
Tsukagoshi M; Department of Innovative Cancer Immunotherapy, Graduate School of Medicine, Gunma University, Maebashi, Japan.
Watanabe A; Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, Graduate School of Medicine, Gunma University, Maebashi, Japan.
Araki K; Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, Graduate School of Medicine, Gunma University, Maebashi, Japan.
Yoshizumi T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shirabe K; Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgery, Graduate School of Medicine, Gunma University, Maebashi, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2022 Jan; Vol. 42 (1), pp. 245-251.
Typ publikacji :
Journal Article
MeSH Terms :
Sustained Virologic Response*
Antigens, Neoplasm/*genetics
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*genetics
Membrane Glycoproteins/*genetics
Aged ; Biomarkers, Tumor/genetics ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/virology ; Disease-Free Survival ; Female ; Galectin 3/genetics ; Glycosylation ; Humans ; Liver Neoplasms/pathology ; Liver Neoplasms/virology ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Hepatitis E Virus Infection-Immune Responses to an Underestimated Global Threat.
Autorzy :
Kupke P; Department of Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Werner JM; Department of Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Sep 02; Vol. 10 (9). Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Immunocompromised Host*
Sustained Virologic Response*
Virus Replication*
Hepatitis E/*immunology
Hepatitis E virus/*immunology
Immunity/*immunology
Animals ; Hepatitis E/epidemiology ; Hepatitis E/virology ; Humans ; Pandemics
Czasopismo naukowe
Tytuł :
Sustained Virologic Response of Patients Hospitalized Compared With Those Not Hospitalized During Treatment for Hepatitis C Virus With Direct-Acting Antivirals.
Autorzy :
Gentene AJ; Department of Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH, USA.; Division of Pharmacy Practice and Administration, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH, USA.
Bell AM; Department of Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH, USA.; Division of Pharmacy Practice and Administration, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH, USA.
Pence A; UC Health Specialty Pharmacy, Cincinnati, OH, USA.
Thomas K; Division of General Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Jakubecz C; Department of Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH, USA.; Division of Pharmacy Practice and Administration, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH, USA.
Stacy E; Department of Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH, USA.; Division of Pharmacy Practice and Administration, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH, USA.
Woolf B; Department of Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH, USA.; Division of Pharmacy Practice and Administration, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH, USA.
Guido MR; Department of Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH, USA.; Division of Pharmacy Practice and Administration, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH, USA.
Mueller EW; Department of Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH, USA.; Division of Pharmacy Practice and Administration, University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, OH, USA.
Sherman KE; Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Pokaż więcej
Źródło :
The Annals of pharmacotherapy [Ann Pharmacother] 2021 May; Vol. 55 (5), pp. 565-574. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Sustained Virologic Response*
Antiviral Agents/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C/*drug therapy
Hospitalization/*trends
Aged ; Antiviral Agents/pharmacology ; Case-Control Studies ; Cohort Studies ; End Stage Liver Disease/diagnosis ; End Stage Liver Disease/drug therapy ; End Stage Liver Disease/epidemiology ; Female ; Hepacivirus/physiology ; Hepatitis C/diagnosis ; Hepatitis C/epidemiology ; Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/epidemiology ; Male ; Middle Aged ; Retrospective Studies ; Treatment Failure ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan.
Autorzy :
Chang KC; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.
Tung SY; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.; Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC.
Wei KL; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.; Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC.
Shen CH; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.
Hsieh YY; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.; Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC.
Chen WM; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.
Chen YH; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.
Chen CH; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.
Yen CW; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.
Xu HW; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.
Tung WL; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.
Hung CH; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.; Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC.
Lu SN; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC.; Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC.
Chang TS; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, No. 6, Section West, Chiapu Road, Puzi, Chiayi, 613, Taiwan, ROC. .; Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Jun 29; Vol. 11 (1), pp. 13543. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Hepatitis C, Chronic*/genetics
Sustained Virologic Response*
Antiviral Agents/*administration & dosage
Hepacivirus/*genetics
Aged ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Lifestyles Associated with Prognosis After Eradication of Hepatitis C Virus: A Prospective Cohort Study in Japan.
Autorzy :
Ohfuji S; Department of Public Health, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abeno-ku, Osaka-shi, Osaka, 545-8585, Japan. .
Matsuura T; Department of Public Health, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abeno-ku, Osaka-shi, Osaka, 545-8585, Japan.
Tamori A; Department of Hepatology, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abeno-ku, Osaka-shi, Osaka, Japan.
Kubo S; Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abeno-ku, Osaka-shi, Osaka, Japan.
Sasaki S; Department of Social and Preventive Epidemiology, School of Public Health, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan.
Kondo K; Osaka City University Hospital, 1-4-3, Asahi-machi, Abeno-ku, Osaka-shi, Osaka, Japan.
Ito K; College of Healthcare Management, 960-4, Takayanagi, Setaka-machi, Miyama-shi, Fukuoka, Japan.
Fukushima W; Department of Public Health, Graduate School of Medicine, Osaka City University, 1-4-3, Asahi-machi, Abeno-ku, Osaka-shi, Osaka, 545-8585, Japan.
Pokaż więcej
Źródło :
Digestive diseases and sciences [Dig Dis Sci] 2021 Jun; Vol. 66 (6), pp. 2118-2128. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepacivirus*/drug effects
Life Style*
Sustained Virologic Response*
Hepatitis C, Chronic/*diagnosis
Hepatitis C, Chronic/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Cohort Studies ; Female ; Hepatitis C, Chronic/drug therapy ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Factors affecting the recovery of hepatic reserve after sustained virologic response by direct-acting antiviral agents in chronic hepatitis C virus-infected patients.
Autorzy :
Nakajima T; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Karino Y; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.; Department of Gastroenterology, Keiyukai Sapporo Hospital, Sapporo, Japan.
Hige S; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Suii H; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Tatsumi R; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Yamaguchi M; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Arakawa T; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Kuwata Y; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Hasegawa T; Department of Radiology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Toyota J; Department of Hepatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2021 Feb; Vol. 36 (2), pp. 367-375. Date of Electronic Publication: 2020 Oct 11.
Typ publikacji :
Journal Article
MeSH Terms :
Recovery of Function*
Sustained Virologic Response*
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Hepatitis C, Chronic/*virology
Liver/*physiopathology
Aged ; Alanine Transaminase ; Carcinoma, Hepatocellular/epidemiology ; Carcinoma, Hepatocellular/etiology ; Female ; Hepacivirus ; Hepatitis C, Chronic/complications ; Hepatitis C, Chronic/physiopathology ; Humans ; Liver Function Tests ; Liver Neoplasms/epidemiology ; Liver Neoplasms/etiology ; Male ; Middle Aged ; Sex Factors
Czasopismo naukowe
Tytuł :
Health information technology interventions and engagement in HIV care and achievement of viral suppression in publicly funded settings in the US: A cost-effectiveness analysis.
Autorzy :
Shade SB; Institute for Global Health Sciences, Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.; Center for AIDS Prevention Studies, University of California, San Francisco, California, United States of America.
Marseille E; Institute for Global Health Sciences, Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America.
Kirby V; Center for AIDS Prevention Studies, University of California, San Francisco, California, United States of America.
Chakravarty D; Center for AIDS Prevention Studies, University of California, San Francisco, California, United States of America.
Steward WT; Center for AIDS Prevention Studies, University of California, San Francisco, California, United States of America.
Koester KK; Center for AIDS Prevention Studies, University of California, San Francisco, California, United States of America.
Cajina A; Demonstration and Evaluation Branch, HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland, United States of America.
Myers JJ; Center for AIDS Prevention Studies, University of California, San Francisco, California, United States of America.
Pokaż więcej
Źródło :
PLoS medicine [PLoS Med] 2021 Apr 07; Vol. 18 (4), pp. e1003389. Date of Electronic Publication: 2021 Apr 07 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Cost-Benefit Analysis*
Sustained Virologic Response*
HIV Infections/*therapy
Health Care Costs/*statistics & numerical data
Medical Informatics/*economics
Medical Informatics/*statistics & numerical data
Humans
Czasopismo naukowe
Tytuł :
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing?
Autorzy :
Lombardi A; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy; Infectious Diseases I Unit, IRCCS 'San Matteo', Pavia, Italy. Electronic address: .
Colaneri M; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Vijayagopal KA; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Sambo M; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Legnazzi P; Pharmacology Unit, IRCCS 'San Matteo', Pavia, Italy.
Sacchi P; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Zuccaro V; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Maiocchi L; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Maserati R; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Gulminetti R; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Pagnucco L; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Novati S; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Zanaboni D; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy.
Michelone G; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy; Infectious Diseases I Unit, IRCCS 'San Matteo', Pavia, Italy.
Ludovisi S; Infectious Diseases I Unit, IRCCS 'San Matteo', Pavia, Italy; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
Mondelli MU; Infectious Diseases I Unit, IRCCS 'San Matteo', Pavia, Italy; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
Bruno R; Infectious Diseases I Unit, IRCCS 'San Matteo', Via Taramelli 5, 27100 Pavia, Italy; Department of Medical, Surgical, Diagnostic and Paediatric Science, University of Pavia, Pavia, Italy.
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 Apr; Vol. 53 (4), pp. 456-460. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article
MeSH Terms :
Sustained Virologic Response*
Antiviral Agents/*therapeutic use
Emigrants and Immigrants/*statistics & numerical data
Hepatitis C, Chronic/*drug therapy
Liver Cirrhosis/*epidemiology
Comorbidity ; Female ; Hepacivirus/drug effects ; Hepatitis C, Chronic/complications ; Humans ; Italy/epidemiology ; Liver Cirrhosis/virology ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Excellent Safety and Sustained Virologic Response to Direct-Acting Antivirals Treatment in HCV-Infected Geriatric Patients: A Real-World Data.
Autorzy :
Huynh T; Department of Pharmacy, University of California Irvine Medical Center, Orange, CA, USA.
Hu KQ; Division of Gastroenterology and Hepatology, University of California Irvine, School of Medicine, 101 The City Drive, Building 56, Ste. 801, Orange, CA, 92868, USA. .
Pokaż więcej
Źródło :
Digestive diseases and sciences [Dig Dis Sci] 2021 Apr; Vol. 66 (4), pp. 1327-1334. Date of Electronic Publication: 2020 May 13.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Data Interpretation, Statistical*
Sustained Virologic Response*
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Hepatitis C, Chronic/*epidemiology
Viral Load/*drug effects
Adult ; Aged ; Aged, 80 and over ; Antiviral Agents ; Female ; Follow-Up Studies ; Hepacivirus/physiology ; Hepatitis C, Chronic/diagnosis ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Viral Load/physiology ; Young Adult
Czasopismo naukowe
Tytuł :
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.
Autorzy :
Lin CP; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Liang PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CI; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, and Center for Cancer Research and Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsu PY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsu CT; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wei YJ; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Liu TW; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Hsieh MY; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Hou NJ; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Jang TY; Department of Internal Medicine, Pingtung Hospital, Ministry of Health and Welfare, Ping-Tung, Taiwan.
Lin YH; Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.
Wang CW; Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, and Center for Cancer Research and Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, and Center for Cancer Research and Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, and Center for Cancer Research and Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, and Center for Cancer Research and Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Occupational Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, and Center for Cancer Research and Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, and Center for Cancer Research and Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, and Center for Cancer Research and Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan.; Insitute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.; Center For Intelligent Drug Systems and Smart Bio-devices (IDS2B) and Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsin-Chu, Taiwan.; Center for Lipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Feb 04; Vol. 16 (2), pp. e0245479. Date of Electronic Publication: 2021 Feb 04 (Print Publication: 2021).
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Sustained Virologic Response*
Antiviral Agents/*administration & dosage
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Adult ; Aged ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Genotype ; Hepatitis C, Chronic/blood ; Hepatitis C, Chronic/virology ; Humans ; Male ; Middle Aged ; RNA, Viral/blood ; RNA, Viral/genetics ; Viral Load
Czasopismo naukowe
Tytuł :
Spontaneous Clearance After Relapse Following Direct-Acting Antiviral Treatment for Chronic HCV Infection.
Autorzy :
Kuriry H; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Casey J; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Krassenburg L; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
La D; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Kuczynski M; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Toronto Viral Hepatitis Care Network, Toronto, Ontario, Canada.
Shah H; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Toronto Viral Hepatitis Care Network, Toronto, Ontario, Canada.
Janssen HLA; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Toronto Viral Hepatitis Care Network, Toronto, Ontario, Canada.
Hansen BE; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Toronto Viral Hepatitis Care Network, Toronto, Ontario, Canada; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Feld JJ; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Toronto Viral Hepatitis Care Network, Toronto, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Nov; Vol. 19 (11), pp. 2398-2406.e1. Date of Electronic Publication: 2020 Jul 03.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Case-Control Studies ; Hepacivirus/genetics ; Humans ; Recurrence ; Sustained Virologic Response
Czasopismo naukowe
Tytuł :
Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial.
Autorzy :
Wei L; Peking University People's Hospital, Peking University Hepatology institute, Beijing, China.
Zhao T; Chongqing International Institute for Immunology, Chongqing, China.
Zhang J; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Mao Q; Infectious Diseases Institute of PLA, Southwest Hospital, Army Medical University, Chongqing, China.
Gong G; Infectious Diseases Department, The Second Xiangya Hospital of Central South University, Changsha, China.
Sun Y; Infectious Diseases Department, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Chen Y; Infectious Diseases Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang M; Infectious Diseases Department, The 81th Hospital of PLA, Nanjing, China.
Tan D; Infectious Diseases Department, Xiangya Hospital of Central South University, Changsha, China.
Gong Z; Infectious Diseases Department, Renmin Hospital of Wuhan University, Wuhan, China.
Li B; Infectious Diseases Department, 302 Military Hospital, Beijing, China.
Niu J; Infectious Diseases Department, The First Hospital of Jilin University, Changchun, China.
Li S; Infectious Diseases Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Gong H; Infectious Diseases Department, The Third Xiangya Hospital of Central South University, Changsha, China.
Zou L; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Zhou W; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Jia Z; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Tang Y; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Fei L; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Hu Y; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Shang X; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Han J; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Zhang B; Department of Immunology, Medical College of Qingdao University, Qingdao, China.
Wu Y; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2022 Jan; Vol. 75 (1), pp. 182-195. Date of Electronic Publication: 2021 Dec 08.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B e Antigens/*blood
Hepatitis B virus/*immunology
Hepatitis B, Chronic/*therapy
Viral Hepatitis Vaccines/*administration & dosage
Adolescent ; Adult ; Double-Blind Method ; Female ; Hepatitis B e Antigens/immunology ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/immunology ; Hepatitis B, Chronic/virology ; Humans ; Injections, Subcutaneous ; Liposomes ; Male ; Nanoparticle Drug Delivery System ; Seroconversion ; Sustained Virologic Response ; Vaccines, Subunit/administration & dosage ; Vaccines, Subunit/adverse effects ; Vaccines, Subunit/chemistry ; Viral Hepatitis Vaccines/adverse effects ; Viral Hepatitis Vaccines/chemistry ; Young Adult
Czasopismo naukowe
Tytuł :
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment.
Autorzy :
Liu CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan.
Chen CY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Su WW; Division of Gastroenterology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.
Tseng KC; Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.; School of Medicine, Tzuchi University, Hualien, Taiwan.
Lo CC; Department of Internal Medicine, St. Martin De Porres Hospital, Daya, Chiayi, Taiwan.
Liu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen JJ; Division of Gastroenterology and Hepatology, Chi-Mei Medical Center, Liouying, Taiwan.
Peng CY; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan.
Shih YL; Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Yang SS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Huang CS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yang Ming Hospital, Chiayi, Taiwan.
Huang KJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, China Medical University Beigang Hospital, Yunlin, Taiwan.
Chang CY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Fu Jen Catholic University Hospital, Taipei, Taiwan.
Tsai MC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Kao WY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Fang YJ; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan.
Chen PY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Su PY; Division of Gastroenterology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.
Tseng CW; Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.; School of Medicine, Tzuchi University, Hualien, Taiwan.
Huang JJ; Department of Internal Medicine, St. Martin De Porres Hospital, Daya, Chiayi, Taiwan.
Lee PL; Division of Gastroenterology and Hepatology, Chi-Mei Medical Center, Liouying, Taiwan.
Lai HC; Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan.
Hsieh TY; Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chang CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Huang YJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Lee FJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Fu Jen Catholic University Hospital, Taipei, Taiwan.
Chang CC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan .; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Gut [Gut] 2022 Jan; Vol. 71 (1), pp. 176-184. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Carbamates/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Heterocyclic Compounds, 4 or More Rings/*therapeutic use
Renal Insufficiency, Chronic/*complications
Ribavirin/*therapeutic use
Sofosbuvir/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Drug Combinations ; Drug Therapy, Combination ; Female ; Hepatitis C, Chronic/complications ; Humans ; Male ; Middle Aged ; Renal Insufficiency, Chronic/classification ; Retrospective Studies ; Sustained Virologic Response ; Young Adult
Czasopismo naukowe
Tytuł :
Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview.
Autorzy :
Bessong PO; AIDS Virus Research Laboratory, HIV/AIDS and Global Health Research Programme, University of Venda, Thohoyandou, 0950, South Africa. .
Matume ND; AIDS Virus Research Laboratory, HIV/AIDS and Global Health Research Programme, University of Venda, Thohoyandou, 0950, South Africa.
Tebit DM; AIDS Virus Research Laboratory, HIV/AIDS and Global Health Research Programme, University of Venda, Thohoyandou, 0950, South Africa.; Global Biomed Scientific LLC, P.O. Box 2368, Forest, VA, 24551, USA.
Pokaż więcej
Źródło :
AIDS research and therapy [AIDS Res Ther] 2021 Jan 06; Vol. 18 (1), pp. 1. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/virology
Sustained Virologic Response*
Adult ; Child ; Cross-Sectional Studies ; Humans ; Prospective Studies ; South Africa ; Viral Load
Czasopismo naukowe
Tytuł :
Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: A meta-analysis.
Autorzy :
Abdrakhman A; School of Medicine, Nazarbayev University, Nur Sultan (Astana), Kazakhstan.
Ashimkhanova A; School of Medicine, Nazarbayev University, Nur Sultan (Astana), Kazakhstan.
Almawi WY; School of Medicine, Nazarbayev University, Nur Sultan (Astana), Kazakhstan; College of Health Sciences, Abu Dhabi University, Abu Dhabi, United Arab Emirates. Electronic address: .
Pokaż więcej
Źródło :
Antiviral research [Antiviral Res] 2021 Jan; Vol. 185, pp. 104995. Date of Electronic Publication: 2020 Dec 13.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Sustained Virologic Response*
Antiviral Agents/*therapeutic use
Hepatitis D, Chronic/*therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Clinical Trials as Topic ; Drug Therapy, Combination ; Hepatitis Delta Virus/drug effects ; Humans ; RNA, Viral ; Recombinant Proteins/therapeutic use ; Seroconversion ; Treatment Outcome ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals.
Autorzy :
Townshend-Bulson L; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Roik E; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Barbour Y; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Bruden DJT; Centers for Disease Control and Prevention, Anchorage, Alaska, United States of America.
Homan CE; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Espera HGF; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Stevenson TJ; Alaska State Virology Laboratory, Anchorage, Alaska, United States of America.
Hewitt AM; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Rhodes W; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Gove JE; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Plotnik JN; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Snowball MM; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
McGilvray J; Pharmacy Department, Southcentral Foundation, Anchorage, Alaska, United States of America.
Simons BC; Centers for Disease Control and Prevention, Anchorage, Alaska, United States of America.
Johnston JM; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
McMahon BJ; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Dec 02; Vol. 16 (12), pp. e0260970. Date of Electronic Publication: 2021 Dec 02 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
American Indians or Alaska Natives/*statistics & numerical data
Antiviral Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Carbamates/*therapeutic use
Fluorenes/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Heterocyclic Compounds, 4 or More Rings/*therapeutic use
Sofosbuvir/*therapeutic use
Adult ; Aged ; Alaska/epidemiology ; Drug Combinations ; Female ; Follow-Up Studies ; Hepacivirus/isolation & purification ; Hepatitis C, Chronic/epidemiology ; Hepatitis C, Chronic/virology ; Humans ; Male ; Middle Aged ; Prognosis ; Sustained Virologic Response
Czasopismo naukowe
Tytuł :
Noninvasive Assessment of Fibrosis Regression after Direct-acting Antiviral Treatment in Hepatitis C Virus Patients.
Autorzy :
Davidov Y; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Kleinbaum Y
Inbar Y; Department of Radiology, Sheba Medical Center, Tel Hashomer, Israel.
Cohen-Ezra O; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Veitsman E; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Weiss P; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Likhter M; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Berdichevski T; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Katsherginsky S; Department of Radiology, Sheba Medical Center, Tel Hashomer, Israel.
Hassid A; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Tsaraf K; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Silverberg D; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.
Ben Ari Z; Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło :
The Israel Medical Association journal : IMAJ [Isr Med Assoc J] 2021 Dec; Vol. 23 (12), pp. 794-800.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*administration & dosage
Hepatitis C, Chronic/*drug therapy
Liver Cirrhosis/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Elasticity Imaging Techniques ; Female ; Follow-Up Studies ; Hepacivirus/drug effects ; Hepatitis C, Chronic/complications ; Humans ; Liver Cirrhosis/virology ; Male ; Middle Aged ; Splenomegaly/epidemiology ; Sustained Virologic Response ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effective Treatment of Chronic Hepatitis C Virus Infection With Ledipasvir/Sofosbuvir in 2 Teenagers With HIV Coinfection: A Brief Report.
Autorzy :
Pokorska-Śpiewak M; From the Department of Children's Infectious Diseases, Medical University of Warsaw.; Department of Pediatric Infectious Diseases, Regional Hospital of Infectious Diseases, Warsaw, Poland.
Dobrzeniecka A; Department of Pediatric Infectious Diseases, Regional Hospital of Infectious Diseases, Warsaw, Poland.
Ołdakowska A; From the Department of Children's Infectious Diseases, Medical University of Warsaw.; Department of Pediatric Infectious Diseases, Regional Hospital of Infectious Diseases, Warsaw, Poland.
Marczyńska M; From the Department of Children's Infectious Diseases, Medical University of Warsaw.; Department of Pediatric Infectious Diseases, Regional Hospital of Infectious Diseases, Warsaw, Poland.
Pokaż więcej
Źródło :
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2021 Dec 01; Vol. 40 (12), pp. 1087-1089.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Fluorenes/*therapeutic use
HIV Infections/*drug therapy
Hepatitis C, Chronic/*drug therapy
Sofosbuvir/*therapeutic use
Adolescent ; Antiviral Agents/administration & dosage ; Benzimidazoles/administration & dosage ; Drug Administration Schedule ; Drug Therapy, Combination ; Fluorenes/administration & dosage ; Genotype ; Humans ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/virology ; Male ; Sofosbuvir/administration & dosage ; Sustained Virologic Response ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019.
Autorzy :
Reau N; Rush University Medical Center, Chicago, IL, USA.
Sulkowski MS; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Thomas E; University of Miami Miller School of Medicine, Miami, FL, USA.
Sundaram V; Department of Medicine and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Xu Q; AbbVie Inc., North Chicago, IL, USA.
Cheng WH; AbbVie Inc., North Chicago, IL, USA.
Marx SE; AbbVie Inc., North Chicago, IL, USA.
Hayes OA; AbbVie Inc., North Chicago, IL, USA.
Manthena SR; AbbVie Inc., North Chicago, IL, USA.
Chirikov V; OPEN Health, Bethesda, MD, USA.
Dylla DE; AbbVie Inc., North Chicago, IL, USA.
Brooks H; AbbVie Inc., North Chicago, IL, USA.
Carabino JM; AbbVie Inc., North Chicago, IL, USA.
Saab S; UCLA Medical Center, 200 Medical Plaza Driveway, Los Angeles, CA, 90095, USA. .
Pokaż więcej
Źródło :
Advances in therapy [Adv Ther] 2021 Dec; Vol. 38 (12), pp. 5777-5790. Date of Electronic Publication: 2021 Oct 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C, Chronic*/diagnosis
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Humans ; Sustained Virologic Response ; United States/epidemiology
Czasopismo naukowe
Tytuł :
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Autorzy :
Sulkowski MS; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.
Moon JS; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.
Sherman KE; Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
Morelli G; Department of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, FL.
Darling JM; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Muir AJ; Division of Gastroenterology, Duke University, Durham, NC.
Khalili M; Department of Medicine, University of California San Francisco, Zuckerberg San Francisco General, Hospital and Trauma Center, San Francisco, CA.
Fishbein DA; Infectious Disease, Medstar Health Research Institute, Washington, DC.
Hinestrosa F; Infectious Disease, Orlando Immunology Center, Orlando, FL.
Shiffman ML; Department of Gastroenterology, Liver Institute of Virginia, Richmond, VA.
Di Bisceglie A; Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO.
Rajender Reddy K; Department of Medicine, University of Pennsylvania, Philadelphia, PA.
Pearlman B; Department of Internal Medicine, Wellstar Health System, Atlanta, GA.
Lok AS; Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
Fried MW; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Stewart PW; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Peter J; Department of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, FL.
Wadsworth S; PRIORITIZE Patient Engagement Group consultant, Garner, NC.
Kixmiller S; PRIORITIZE Patient Engagement Group consultant, Greensboro, NC.
Sloan A; PRIORITIZE Patient Engagement Group consultant, Pittsboro, NC.
Vainorius M; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Horne PM; Department of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, FL.
Michael L; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Dong M; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Evon DM; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Segal JB; Division of Internal Medicne, Johns Hopkins University School of Medicine, Baltimore, MD.
Nelson DR; Department of Gastroenterology, Hepatology & Nutrition, University of Florida, Gainesville, FL.
Pokaż więcej
Corporate Authors :
PRIORITIZE Study Team
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2021 Dec; Vol. 74 (6), pp. 2952-2964. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji :
Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Pragmatic Clinical Trial; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*administration & dosage
Hepacivirus/*isolation & purification
Hepatitis C, Chronic/*drug therapy
2-Naphthylamine/administration & dosage ; Administration, Oral ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anilides/administration & dosage ; Benzimidazoles/administration & dosage ; Benzofurans/administration & dosage ; Cyclopropanes/administration & dosage ; Drug Combinations ; Drug Therapy, Combination/methods ; Female ; Fluorenes/administration & dosage ; Follow-Up Studies ; Genotyping Techniques ; Hepacivirus/genetics ; Hepatitis C, Chronic/blood ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/virology ; Humans ; Imidazoles/administration & dosage ; Lactams, Macrocyclic/administration & dosage ; Male ; Middle Aged ; Proline/administration & dosage ; Proline/analogs & derivatives ; Quinoxalines/administration & dosage ; RNA, Viral/blood ; Ribavirin/administration & dosage ; Sofosbuvir/administration & dosage ; Sulfonamides/administration & dosage ; Sustained Virologic Response ; Treatment Outcome ; Uracil/administration & dosage ; Uracil/analogs & derivatives ; Valine/administration & dosage ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies